Black Rock Inc. Krystal Biotech, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,947,845 shares of KRYS stock, worth $773 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,947,845
Previous 1,805,379
118.67%
Holding current value
$773 Million
Previous $321 Million
125.69%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding KRYS
# of Institutions
287Shares Held
24.9MCall Options Held
270KPut Options Held
177K-
Vanguard Group Inc Valley Forge, PA2.87MShares$562 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$477 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$261 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$200 Million12.22% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$194 Million10.7% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.03B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...